Realtime AI News
DeepSeek Launches New Funding Round at ¥480 Billion Valuation, Eyes IPO Next Year
DeepSeek has rapidly launched a new funding round at a ¥480 billion ($66 billion) valuation, a 37% increase from its first round. Sources indicate the company may pursue an IPO as early as next year.

DeepSeek has rapidly initiated a new funding round, reaching a valuation of ¥480 billion (approximately $66 billion). According to reports from QbitAI, this represents a 37% increase from DeepSeek's first funding round.
The new round comes shortly after DeepSeek's initial fundraising, reflecting strong capital market appetite for the Chinese AI startup. DeepSeek has gained global recognition in the AI community for its high-performance open-source models that rival top closed-source alternatives on multiple benchmarks.
Sources indicate that DeepSeek could pursue an IPO as early as next year. If realized, this would become one of the most closely watched Chinese AI company public listings in recent years.
DeepSeek's rapid rise has challenged the industry assumption that AI development requires massive capital investment. The company trained its leading models at a fraction of the cost of its US counterparts, sparking widespread discussion across Silicon Valley.
With the new funding, DeepSeek is expected to accelerate model research and development, expand its computing infrastructure, and advance its commercialization strategy. The market will be watching closely for the investor lineup and the specific timeline for any potential IPO.
It should be noted that IPO timing remains subject to market conditions and regulatory approvals.
Why it matters
DeepSeek's ¥480 billion funding round and potential IPO signal sustained capital momentum in China's AI sector, with the efficient open-source approach reshaping the global AI competitive landscape.
Nearby Updates
All07/15, 08:27
OpenAI Researcher Miles Wang in Talks to Launch AI Drug Discovery Startup Valued at $2B
OpenAI researcher Miles Wang is in discussions to launch an AI drug discovery startup reportedly valued at $2 billion. The funding talks highlight strong investor interest in applying artificial intelligence to accelerate breakthroughs in life sciences.
07/15, 07:55
StepFun CEO Yin Qi Charts 'Chicken and Egg Together' Strategy, Diverging from Zhipu and Doubao
StepFun founder and CEO Yin Qi stated in an interview with Times Online that the company will develop foundational models and end-user applications simultaneously, rather than building the model first and then layering applications on top. This positions StepFun on a distinct path from peers like Zhipu (model-focused) and Doubao (application-focused).
07/15, 09:59
Australia Announces Creation of Office of AI
Australian Prime Minister Anthony Albanese has announced the creation of an Office of AI to strengthen the country's AI governance and development. The move marks a significant step in Australia's approach to AI regulation and industry promotion.
07/15, 07:44
Ripple Joins x402 Foundation, Bringing XRP to AI Agent Payments
Ripple has officially joined the x402 Foundation, pushing XRP into the AI agent autonomous payment space. The x402 protocol is designed to enable AI agents to initiate and complete payments without human intervention, and Ripple's membership brings a mature blockchain payment network to this emerging infrastructure.